Pay Attention to this Trade Activity as Edwards Lifesciences Corp (EW) last week performance was -5.79%

Witnessing the stock’s movement on the chart, on Thursday, Edwards Lifesciences Corp (NYSE: EW) had a quiet start as it plunged -0.60% to $69.86, before settling in for the price of $70.28 at the close. Taking a more long-term approach, EW posted a 52-week range of $58.93-$96.12.

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 8.65%. Meanwhile, its Annual Earning per share during the time was 15.35%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.32%. This publicly-traded company’s shares outstanding now amounts to $589.80 million, simultaneously with a float of $579.26 million. The organization now has a market capitalization sitting at $41.20 billion. At the time of writing, stock’s 50-day Moving Average stood at $71.36, while the 200-day Moving Average is $76.69.

Edwards Lifesciences Corp (EW) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Edwards Lifesciences Corp’s current insider ownership accounts for 1.79%, in contrast to 84.85% institutional ownership. According to the most recent insider trade that took place on Jan 16 ’25, this organization’s CVP, JAPAC sold 500 shares at the rate of 68.76, making the entire transaction reach 34,382 in total value, affecting insider ownership by 23,189. Preceding that transaction, on Jan 16 ’25, Company’s CVP,Strategy/Corp Development sold 5,000 for 68.75, making the whole transaction’s value amount to 343,736. This particular insider is now the holder of 46,936 in total.

Edwards Lifesciences Corp (EW) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.

Edwards Lifesciences Corp’s EPS increase for this current 12-month fiscal period is 2.32% and is forecasted to reach 2.44 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.00% through the next 5 years, which can be compared against the 15.35% growth it accomplished over the previous five years trading on the market.

Edwards Lifesciences Corp (NYSE: EW) Trading Performance Indicators

Let’s observe the current performance indicators for Edwards Lifesciences Corp (EW). It’s Quick Ratio in the last reported quarter now stands at 2.89. The Stock has managed to achieve an average true range (ATR) of 1.76. Alongside those numbers, its PE Ratio stands at $10.08, and its Beta score is 1.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.02. Similarly, its price to free cash flow for trailing twelve months is now 79.93.

In the same vein, EW’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.93, a figure that is expected to reach 0.55 in the next quarter, and analysts are predicting that it will be 2.44 at the market close of one year from today.

Technical Analysis of Edwards Lifesciences Corp (EW)

Going through the that latest performance of [Edwards Lifesciences Corp, EW]. Its last 5-days volume of 4.26 million indicated improvement to the volume of 4.15 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 19.23% While, its Average True Range was 1.76.

Raw Stochastic average of Edwards Lifesciences Corp (EW) in the period of the previous 100 days is set at 47.89%, which indicates a major rise in contrast to 20.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 19.08% that was lower than 25.57% volatility it exhibited in the past 100-days period.